In the United States, large barriers remain for women with cancer who want to preserve their fertility, explained Dr. Levine. For instance, while fertility preservation is available to all women in Sweden under their national health system, many insurance plans in the United States don’t cover it for young cancer patients.
Read More »Steroids May Limit the Effectiveness of Immunotherapy for Brain Cancer
Some patients receive dexamethasone to prevent inflammation in the brain and remain on the medicine indefinitely. But, based on the new findings, it may be time to reevaluate how dexamethasone is used in brain cancer, the researchers suggested.
Read More »Study of “exceptional responders” yields clues to cancer and potential treatments
USA, 19th November 2020. In a comprehensive analysis of patients with cancer who had exceptional responses to therapy, researchers have identified molecular changes in the patients’ tumours that may explain some of the exceptional responses. The results demonstrate that genomic characterizations of cancer can uncover genetic alterations that may contribute …
Read More »Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma
Washington DC. 26th May 2020. In a new study, an alternative treatment regimen that is less toxic than standard dose-intensive chemotherapy was found to be highly effective for adults with Burkitt lymphoma across all age groups and independent of HIV status. In addition to being better tolerated, the regimen, called …
Read More »Should we delay Blood cancer treatment during Corona Virus Pandemic?
Blood cancer called acute Leukemia is ‘The most dangerous and life-threatening Cancer’ where early initiation of treatment makes a huge difference in patient outcome. Clinical Presentation of Blood cancer is variable ranging from Incidental detection on blood tests to breathing difficulty and fever. These symptoms trigger Corona testing and Isolation. …
Read More »In NIH trial, selumetinib shrinks tumors, provides clinical benefit for children with NF1
New York. 19th March 2020 : Findings from a phase 2 clinical trial show that the drug selumetinib improves outcomes for children with the genetic disorder neurofibromatosis type 1 (NF1). In the trial, selumetinib shrank the inoperable tumors that develop with NF1 called plexiform neurofibromas, and children experienced reduced pain, …
Read More »Study provides genetic insights into osteosarcoma in children
New York 19th March 2020 : A study by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, offers new insight into genetic alterations associated with osteosarcoma, the most common cancerous bone tumour of children and adolescents. The researchers found that more people with osteosarcoma …
Read More »In India, around 5.8 lakh new cases of cancers were diagnosed in women in 2018
In 2020, American Oncology Institute will create 2020 Nyla Volunteers across 13 states in India American Oncology Institute announces the launch of its exclusive Campaign for ‘Cancers in Women’- NYLA, a movement for early detection and prevention of Cancers in Women Hyderabad, February 09, 2020: American Oncology Institute (AOI), South …
Read More »Global cancer burden expected to rise by 60% by 2040!
World Cancer Day – February 4, 2020 February 4, 2020, will mark the 20th anniversary of World Cancer Day, an annual event meant to raise cancer awareness and encourage governments, oncology societies, nongovernmental organizations, businesses, and individuals to take action against the global impact of the disease. This has been …
Read More »Artificial intelligenc can jump-start radiation therapy for cancer patients
instantly generates dosage plan, avoids potentially crucial delay DALLAS – Jan. 27, 2020 – Artificial intelligence can help cancer patients start their radiation therapy sooner – and thereby decrease the odds of the cancer spreading – by instantly translating complex clinical data into an optimal plan of attack. Patients typically …
Read More »UT Southwestern cancer experts catalog, map kidney cancer tumors and progression
DALLAS – Jan. 13, 2020 – Researchers at the Kidney Cancer Program at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center have developed what could be the most complete catalog of clear cell renal cell carcinoma, the most common type of kidney cancer. Known as ccRCC, this cancer …
Read More »Apollo Doctors perform Living Donor Liver Transplant and CABG, in one sitting spanning over a gruelling 14 hours!
The treatment involved expertise of multiple specialities including Liver transplant, Oncology & Cardiac teams
Read More »Criteria for clinical trials might be too strict, needlessly excluding patients
Clinical trial eligibility criteria are designed to limit risks to study participants. But, according to Dr. Gerber, these criteria may be excessive in places.
Read More »Immunotherapy drug improves outcomes for some children with relapsed leukemia
leukemia relapse survival rate children : Immunotherapy drug improves outcomes for some children with relapsed leukemia. Chemotherapy can produce severe side effects.
Read More »Modern breast cancer care coupled with patient’s positive attitude can enable to conquer cancer!
Breast cancer is a malignant tumor - a tumor with the potential to invade other tissues or spread to other parts of the body.
Read More »Fewer Women with Ovarian, Breast Cancer Undergo Genetic Testing than Expected
Tests for inherited genetic mutations can provide women diagnosed with ovarian or breast cancer with important information that can have implications for family members and potentially guide treatment decisions and longer-term screening for second cancers.
Read More »Analysis Shows Women with High Breast Cancer Recurrence Scores Benefit from Chemo
For women with the most common type of early-stage breast cancer and high scores on the Oncotype DX test, receiving chemotherapy with hormone therapy after surgery can lead to excellent long-term outcomes.
Read More »Breaking news : After a Breast Cancer Diagnosis, Men May Be More Likely to Die than Women
Men may be more likely than women to die after being diagnosed with breast cancer, particularly during the first 5 years after diagnosis, a new study suggests.
Read More »For Children with Neuroblastoma, Trial Results Highlight Continued Evolution of Treatment
For many children with advanced forms of neuroblastoma, receiving two separate stem cell transplants as part of their treatment is more beneficial than receiving one.
Read More »Selpercatinib Shows Promise against Lung Cancers with Alterations in RET Gene
Selpercatinib (LOXO-292) is a targeted therapy that works by inhibiting the activity of abnormal RET proteins. The drug is an oral therapy that patients take as a pill.
Read More »
You must be logged in to post a comment.